Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Rare Disease Group, |
RCV000754953 | SCV000788379 | likely pathogenic | Jeune thoracic dystrophy | 2018-05-01 | criteria provided, single submitter | research | |
Rare Disease Group, |
RCV000984620 | SCV000924633 | likely pathogenic | Jeune thoracic dystrophy; Familial aplasia of the vermis | 2019-06-11 | criteria provided, single submitter | clinical testing | This synonymous variant has been shown to affect splicing, leading to skipping of exon 4 in the KIAA0753 protein (shown by sequencing cDNA from homozygous individual). Four deceased patients (from two families) with SRTD and JBTS phenotype are homozygous for this variant. In summary, this seemingly synonymous variant affect splicing and should be considered as likely pathogenic. |
Clinical Genetics and Genomics, |
RCV001269992 | SCV001450399 | likely pathogenic | not provided | 2018-11-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001269992 | SCV001990247 | uncertain significance | not provided | 2019-09-09 | criteria provided, single submitter | clinical testing | In-silico analysis, which includes splice predictors and evolutionary conservation, is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; Nucleotide substitution is not conserved across species; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV001269992 | SCV002431093 | likely benign | not provided | 2022-11-10 | criteria provided, single submitter | clinical testing | |
OMIM | RCV001559339 | SCV001781548 | pathogenic | Short-rib thoracic dysplasia 21 without polydactyly | 2021-10-07 | no assertion criteria provided | literature only |